Saba Capital Management L.P. Buys New Position in BlackRock Health Sciences Term Trust $BMEZ

Saba Capital Management L.P. bought a new stake in BlackRock Health Sciences Term Trust (NYSE:BMEZ) in the 1st quarter, according to its most recent disclosure with the SEC. The fund bought 759,506 shares of the company’s stock, valued at approximately $10,907,000.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Kestra Advisory Services LLC acquired a new stake in shares of BlackRock Health Sciences Term Trust during the fourth quarter worth about $26,000. SouthState Bank Corp acquired a new position in shares of BlackRock Health Sciences Term Trust in the first quarter valued at approximately $29,000. PNC Financial Services Group Inc. purchased a new stake in BlackRock Health Sciences Term Trust during the 1st quarter worth approximately $35,000. Geneos Wealth Management Inc. purchased a new stake in BlackRock Health Sciences Term Trust during the 1st quarter worth approximately $40,000. Finally, Allworth Financial LP increased its stake in BlackRock Health Sciences Term Trust by 24,584.6% during the 3rd quarter. Allworth Financial LP now owns 3,209 shares of the company’s stock worth $46,000 after buying an additional 3,196 shares during the period.

BlackRock Health Sciences Term Trust Trading Up 0.2%

BlackRock Health Sciences Term Trust stock opened at $15.34 on Tuesday. BlackRock Health Sciences Term Trust has a 52-week low of $13.67 and a 52-week high of $15.80. The company’s 50 day moving average is $14.85 and its two-hundred day moving average is $14.73.

BlackRock Health Sciences Term Trust Dividend Announcement

The business also recently disclosed a monthly dividend, which will be paid on Wednesday, September 30th. Stockholders of record on Tuesday, September 15th will be given a dividend of $0.11 per share. The ex-dividend date of this dividend is Tuesday, September 15th. This represents a c) dividend on an annualized basis and a dividend yield of 8.6%.

BlackRock Health Sciences Term Trust Profile

BlackRock Health Sciences Term Trust (NYSE: BMEZ) is a closed-end management investment company organized as a Delaware statutory trust. Launched in March 2020, BMEZ seeks to provide total return through a combination of current income and capital appreciation by investing primarily in equity and equity-related securities of companies in the health sciences sector. The trust is structured with a fixed termination date in October 2030, at which time shareholders will vote on its liquidation, extension or conversion.

The fund’s investment portfolio is diversified across subsectors within health sciences, including biotechnology, pharmaceuticals, medical devices, diagnostics and healthcare services.